75 filings
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
7 May 24
Submission of Matters to a Vote of Security Holders
4:18pm
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
3 May 24
Amneal Reports First Quarter 2024 Financial Results
6:14am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
1 Mar 24
Amneal Reports Fourth Quarter and Full Year 2023 Financial Results
6:13am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
10 Jan 24
Results of Operations and Financial Condition
7:03am
8-K
AMRX
Amneal Pharmaceuticals Inc - Ordinary Shares
15 Dec 23
Amneal Announces Move to Nasdaq
4:15pm
8-K/A
anmqeb9ae69167nit1z0
15 Dec 23
Financial Statements and Exhibits
4:06pm
8-K
1znxkkzhoby
14 Nov 23
Entry into a Material Definitive Agreement
5:04pm
8-K
20k8ekx87 zu44umtj
7 Nov 23
Amneal Reports Third Quarter 2023 Financial Results
6:21am
8-K
2nqcbp312f emzpcz
23 Oct 23
Amneal Reports Certain Preliminary Third Quarter 2023 Financial Results
4:16pm
8-K
rxyq aqvb1x26xtoz
17 Oct 23
Entry into a Material Definitive Agreement
6:51am
8-K
tosf l3nqz8jldd1ww2n
4 Aug 23
Amneal Reports Second Quarter 2023 Financial Results
6:22am
8-K
4bxgo7oat
19 May 23
In the Court of Chancery of the State of Delaware
4:06pm
8-K
tip fedusny
12 May 23
Submission of Matters to a Vote of Security Holders
4:29pm
8-K
v89tj1p4xoyywsyb
5 May 23
Amneal Reports First Quarter 2023 Financial Results
6:17am
8-K
i3fk35
17 Apr 23
Amneal Reports Certain Preliminary First Quarter 2023 Financial Results
6:43am
8-K
uo91c7m4xm49dqm6u7h
2 Mar 23
Amneal Reports Fourth Quarter and Full Year 2022 Financial Results
6:27am
8-K
w6x42n
10 Jan 23
Results of Operations and Financial Condition
6:05am
8-K
6bf9tyh0l9pxbx 0i9v
4 Nov 22
Amneal Reports Third Quarter 2022 Financial Results
6:24am
8-K
es5ru76pptlfg
6 Sep 22
Amneal Appoints Gustavo Pesquin as Executive Vice President, Chief Commercial Officer – Specialty
4:15pm
8-K
z3t q0ckh
5 Aug 22
Amneal Reports Second Quarter 2022 Financial Results
6:11am